Legend Biotech Corp (LEGN) — Capital Reinvestment Ratio
Legend Biotech Corp (LEGN) has a Capital Reinvestment Ratio of 0.17x as of September 2025, meaning it reinvests 0% of its operating cash flow ($28.80 Million) in capital expenditures ($5.00 Million). See Legend Biotech Corp balance sheet independence to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Legend Biotech Corp Capital Reinvestment Ratio (2018–2018)
This chart tracks Legend Biotech Corp's Capital Reinvestment Ratio across 1 annual periods. Check Legend Biotech Corp (LEGN) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Legend Biotech Corp (2018–2018)
Year-by-year Capital Reinvestment Ratio for Legend Biotech Corp from 2018 to 2018. For live market cap and broader valuation context, see LEGN stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2018 | 0.07x | $307.68 Million | $21.02 Million | — |